Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. It appears above the ClinicalTrials.gov error message.
    Difference
    1%
    Check dated 2026-10-25T02:07:28.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:56:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision advanced from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:28:58.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Added a new Revision: v3.7.0 tag and removed a broad list of metadata terms and keywords. This updates how the record is indexed and what topics are associated with it, without changing core study content.
    Difference
    18%
    Check dated 2026-09-20T01:31:05.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page displays a newer revision number (v3.6.6) replacing the previous v3.6.5, signaling that the ClinicalTrials.gov record was refreshed.
    Difference
    0.1%
    Check dated 2026-08-29T23:44:00.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.5) appears, and the related topics block including 'Prostate cancer' and 'MedlinePlus Genetics' along with the prior revision tag ('Revision: v3.6.4') has been removed.
    Difference
    0.2%
    Check dated 2026-08-08T18:13:50.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.